Publications

p120-catenin prevents multinucleation through control of MKLP1-dependent RhoA activity during cytokinesis.

Authors: RAH van de Ven, JS de Groot, D Park, R van Domselaar, D de Jong, K Szuhai, ...

E-pub date: 22 Dec 2016

Journal name: Nat Commun

Label-free monitoring of tissue biochemistry following traumatic brain injury using Raman spectroscopy.

Authors: JM Surmacki, L Ansel-Bollepalli, F Pischiutta, ER Zanier, A Ercole, SE Bohn...

E-pub date: 19 Dec 2016

Journal name: Analyst

Pancreatic stellate cell heterogeneity in cancer

Authors: D Ohlund, A Handly-Santana, E Elyada, G Biffi, DA Tuveson

E-pub date: 15 Dec 2016

Journal name: Cancer Research

BaalChIP: Bayesian analysis of allele-specific transcription factor binding in cancer genomes

Authors: I de Santiago, W Liu, M O’Reilly, K Yuan, CSR Chilamakuri, BAJ Ponder, K ...

E-pub date: 12 Dec 2016

Journal name:

FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3.

Authors: KM Jozwik, I Chernukhin, AA Serandour, S Nagarajan, JS Carroll

E-pub date: 6 Dec 2016

Journal name: Cell Rep

Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study.

Authors: HR Ali, L Chlon, PDP Pharoah, F Markowetz, C Caldas

E-pub date: 1 Dec 2016

Journal name: PLoS Med

Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study.

Authors: CA Parkinson, D Gale, AM Piskorz, H Biggs, C Hodgkin, H Addley, S Freeman, ...

E-pub date: 1 Dec 2016

Journal name: PLoS Med

Feasibility of monitoring response to the PARP inhibitor rucaparib with targeted deep sequencing of circulating tumor DNA (ctDNA) in women with high grade ovarian carcinoma on the ARIEL2 trial

Authors: AM Piskorz, KK Lin, J Morris, E Mann, A Oza, RL Coleman, DM O'Malley, M Fri...

E-pub date: 1 Dec 2016

Journal name: European Journal of Cancer

Filters

Research Groups

Core Facilities

Start date

End date

p120-catenin prevents multinucleation through control of MKLP1-dependent RhoA activity during cytokinesis.

Label-free monitoring of tissue biochemistry following traumatic brain injury using Raman spectroscopy.

Pancreatic stellate cell heterogeneity in cancer

BaalChIP: Bayesian analysis of allele-specific transcription factor binding in cancer genomes

FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3.

Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study.

Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study.

Feasibility of monitoring response to the PARP inhibitor rucaparib with targeted deep sequencing of circulating tumor DNA (ctDNA) in women with high grade ovarian carcinoma on the ARIEL2 trial

Themes

Filters

Research Groups

Core Facilities

Start date

End date

p120-catenin prevents multinucleation through control of MKLP1-dependent RhoA activity during cytokinesis.

Label-free monitoring of tissue biochemistry following traumatic brain injury using Raman spectroscopy.

Pancreatic stellate cell heterogeneity in cancer

BaalChIP: Bayesian analysis of allele-specific transcription factor binding in cancer genomes

FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3.

Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study.

Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study.

Feasibility of monitoring response to the PARP inhibitor rucaparib with targeted deep sequencing of circulating tumor DNA (ctDNA) in women with high grade ovarian carcinoma on the ARIEL2 trial